GSK appoints consumer head as CEO of new spin-off
Reuters
Published Jul 22, 2021 16:18
(Reuters) - British drugmaker GSK said on Thursday its consumer healthcare head, Brian McNamara, will take over as the chief executive officer of the unit once it is spun off into a new company next year.
GSK in June laid out plans to divest its consumer arm, a joint venture with Pfizer Inc (NYSE:PFE) that includes brands such as Sensodyne toothpaste and Advil painkillers, in its biggest shake-up in two decades.
The company also rejected activist investor Elliott Management's demand earlier this month to review its leadership, and said CEO Emma Walmsley will remain in her role after the spin-off.
McNamara, who GSK said was appointed to lead the new company after an "extensive search and selection", joined the pharma major in 2015 from Novartis, where he headed the over the counter products division.
"His strong track record of success and deep experience of fast moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice," said GSK Chairman Jonathan Symonds.
The appointment of a chair for the new consumer healthcare company is expected in the second half of 2021, GSK said, adding that the chair would then lead the formation of the new board.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.